Peptides

Items 2601-2650 of 3079

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Melanocortin Peptide

    δ-MSH is a melanocortin peptide that acts as a weak ligand for melanocortin receptors (MCRs). It plays a role in various biological processes, including appetite regulation and energy homeostasis. δ-MSH is valuable for research applications focusing on neuroendocrine functions and studies of metabolic disorders.
  2. Melanocortin Peptide

    Lys-γ3-MSH (human) is a melanocortin peptide that targets the melanocortin receptor system, derived from the C-terminal fragment of pro-opiomelanocortin (POMC). It effectively enhances the steroidogenic response of adrenal cells to adrenocorticotrophin (ACTH) and exhibits potent lipolytic activity with an EC50 of 3.56 nM. Lys-γ3-MSH activates hormone-sensitive lipase (HSL) and Perilipin A, making it valuable for research in metabolic regulation and obesity-related studies.
  3. ACTH Derivative Peptide

    Ebiratide is an ACTH 4-9 derivative peptide that acts on the central nervous system to enhance cognitive function. It has been shown to improve memory by promoting acetylcholine metabolism within the rat brain. This compound is valuable for research into neurodegenerative diseases and cognitive disorders.
  4. Natriuretic Peptide

    Rolzavosoritide is a C-type natriuretic peptide that primarily targets natriuretic peptide receptors. This compound is involved in modulating vascular homeostasis, reducing cardiac hypertrophy, and promoting diuresis. It is being investigated for its potential applications in treating heart failure and other cardiovascular diseases.
  5. Atrial Natriuretic Peptide

    Anaritide is a synthetic analogue of atrial natriuretic peptide (ANP) consisting of 25 amino acids. It primarily functions by enhancing glomerular filtration rate through the dilation of afferent arterioles and contraction of efferent arterioles. This reagent is valuable for investigating its impact on acute tubular necrosis and may contribute to improved dialysis-free survival in affected patients.
  6. Neuropeptide

    BNP(1-32), porcine is an atrial natriuretic peptide that primarily targets neuropeptide pathways. This cardiac hormone exhibits significant natriuretic, diuretic, and vasorelaxant effects, making it valuable for cardiovascular research. Furthermore, BNP(1-32) has been shown to influence passive avoidance learning in rodent models, highlighting its potential role in neurobiology studies involving dopaminergic and cholinergic systems, as well as adrenergic receptor interactions.
  7. Peptide

    BNP (1-21), Pro (Human) is a 21-amino acid peptide and a member of the B-type natriuretic peptide family, a cardiac natriuretic hormone. It plays a crucial role in regulating cardiovascular function by promoting natriuresis, diuresis, and vasodilation. Research applications include studies on heart organogenesis and the physiological adaptations during the transition to extrauterine life. BNP serves as an important biomarker in various cardiovascular diseases and helps elucidate the underlying mechanisms of heart function and development.
  8. ANP Peptide Fragment

    Atrial Natriuretic Peptide (7-28), human, canine is a bioactive peptide fragment derived from atrial natriuretic peptide (ANP). This fragment plays a crucial role in cardiovascular homeostasis by promoting natriuresis and vasodilation. It is primarily utilized in research applications focusing on cardiovascular function, heart failure, and the regulatory effects of natriuretic peptides. Additionally, this peptide can serve as a useful tag for various biochemical assays.
  9. Hypotensive and Diuretic Agent

    Brain Natriuretic Peptide-45, rat is a potent hypotensive and diuretic agent derived from rat heart tissue. This circulating form of rat brain natriuretic peptide plays a critical role in regulating blood pressure and sodium homeostasis. Its biological activity is essential for research applications focusing on cardiovascular physiology, heart failure, and fluid balance in animal models.
  10. ANP Analog

    [Tyr8]-Atrial Natriuretic Peptide (5-27), rat is an analog of atrial natriuretic peptide (ANP) that primarily targets smooth muscle relaxation. This peptide is characterized by its ability to induce vasodilation while maintaining stable cGMP levels. Its unique properties make it a valuable tool for research in cardiovascular physiology and pharmacology, particularly in studies examining the regulatory mechanisms of blood pressure and fluid homeostasis.
  11. Atrial Peptide

    [Mpr7, DAla9] ANP (7-28), amide, rat is a modified atrial natriuretic peptide that acts on the NPR-A receptor. This reagent exhibits significant vasodilatory effects and plays a crucial role in regulating cardiovascular homeostasis. It is widely used in research to study cardiac function, blood pressure regulation, and the pathophysiology of heart failure.
  12. Peptide Neurotransmitter

    Neurokinin A TFA is a peptide neurotransmitter belonging to the tachykinin family, primarily targeting the NK-2 receptor. This compound plays a significant role as a mediator in human airway and gastrointestinal tissues, influencing smooth muscle contraction and various physiological processes. It is extensively utilized in research applications exploring neurogenic inflammation, pain signaling, and gastrointestinal motility.
  13. Neurokinin Receptor Activator

    Eledoisin Related Peptide is a neurokinin receptor activator that functions as an analog of Substance P. This peptide is known to stimulate neurons, resulting in various behavioral responses. It serves as a valuable tool for research applications focused on neurokinin signaling pathways and tachykinin receptor interactions.
  14. Neuropeptide Substance P Antagonist

    Octahydroisoindole is a neuropeptide Substance P antagonist that effectively crosses the blood-brain barrier. This compound is vital for investigating movement disorders linked to central nervous system diseases, enabling researchers to explore its potential therapeutic applications in conditions such as pain and neurodegeneration.
  15. C-terminal Tripeptide of Substance P

    Gly-Leu-Met-NH2 is a C-terminal tripeptide derived from Substance P, a neuropeptide known for its role in pain transmission and inflammation. This compound exhibits neuroactive properties that can be utilized in research applications related to neurobiology, pain mechanisms, and neuroinflammatory processes. Its structural similarity to Substance P makes it a valuable tool for studying receptor interactions and signaling pathways associated with neuropeptide functions.
  16. NK2 Receptor Agonist

    γ-Neuropeptide (rabbit) is an endogenous peptide that acts as an agonist for the neurokinin 2 (NK2) receptor. It plays a significant role in regulating the hypothalamic-pituitary-adrenal (HPA) axis and the release of reproductive hormones. This reagent is valuable for studies investigating neurokinin signaling pathways and their implications in stress response and reproductive health.
  17. Neuropeptide

    Substance P (6-11) is a neuropeptide specifically targeting the NK-1 tachykinin receptor. This C-terminal hexapeptideamide derivative of Substance P demonstrates significant biological activity, including the depolarization of motoneurons and a hypotensive effect. It serves as a valuable tool in research applications focused on neurobiology, pain modulation, and cardiovascular studies.
  18. Neuromessenger

    Neuropeptide K is a tachykinin neuromessenger that plays a crucial role in facilitating intercellular communication within the central nervous system. It is involved in various biological activities, such as gallbladder contraction, protein extravasation, hypotension, and bronchial smooth muscle spasms. This reagent is derived from human, porcine, and rat sources, making it suitable for research applications aimed at exploring neuropeptide signaling and its implications in physiological and pathophysiological processes.
  19. Neuropeptide

    Substance P (5-11) is a neuropeptide that primarily targets the NK-1 tachykinin receptor. As a C-terminal heptapeptide of the full Substance P, it plays a critical role in pain transmission and neurogenic inflammation. This compound is commonly used in research applications focused on pain pathways, neurobiology, and receptor pharmacology, providing insights into the functions and mechanisms of neuropeptide activity.
  20. Peptide

    [Tyr8,Nle11] Substance P is an analog of the neuropeptide Substance P, which primarily targets neurokinin receptors. This peptide plays a significant role in various biological processes, including pain transmission and inflammatory responses. It is widely used in research to study nociceptive pathways and the modulation of inflammatory conditions.
  21. Octapeptide

    [Glp5] Substance P (5-11) is an octapeptide that primarily targets neurokinin receptors. This fragment of substance P plays a significant role in the central nervous system (CNS) of rats, where it is known to modulate dopamine release in the striatum. Its ability to influence neurotransmitter dynamics makes it valuable for research in neuropharmacology and studies related to CNS functions and disorders.
  22. Peptide

    ApoA-I mimetic peptide is a synthetic peptide designed to mimic the activity of apolipoprotein A-I, targeting lipid metabolism pathways. It exhibits effective activation of lecithin:cholesterol acyltransferase (LCAT), facilitating the formation of peptide/lipid complexes. This reagent is useful in research related to atherosclerosis, aiding in the study of cholesterol regulation and plaque formation. The peptide sequence is PVLDLFRELLNELLEALKQKLK.
  23. Cationic Amphiphilic Lytic Peptide

    L17E is an attenuated cationic amphiphilic lytic peptide that facilitates the delivery of macromolecules, including proteins, antibodies, and DNA nanostructures. Its mechanism involves membrane insertion and cleavage via electrostatic interactions, promoting intracellular escape. The effectiveness of L17E is closely linked to the expression of KCNN4, encoding the calcium-activated potassium channel KCa3.1, and it enhances cellular uptake through the induction of micropinocytosis. Additionally, L17E can be optimized through dimerization and combined with other delivery systems, such as nuclear localization signal peptides and cell membrane-coated nanoparticles, for improved performance in research applications.
  24. Neuroactive peptide

    β-Bag cell peptide is a neuroactive peptide that primarily acts on bag cell neurons, elevating cyclic AMP levels. This elevation in cyclic AMP is associated with the modulation of neurophysiological processes, while β-Bag cell peptide also reduces the amplitudes of voltage-dependent potassium currents. This compound is useful for studies exploring neuronal signaling pathways and the physiological roles of neuropeptides in the nervous system.
  25. Bioactive Peptide

    Caloxin 1B1 is a bioactive peptide that selectively targets the extracellular domain 1 of the plasma membrane calcium ATPase 4 (PMCA4). Its high affinity for PMCA4, compared to PMCA1, enables effective modulation of calcium transport. Caloxin 1B1 can be directly applied to cells and tissues, making it a valuable tool for investigating its effects on smooth muscle and endothelial function in various research applications.
  26. Neuropeptide

    Substance P (alligator) is a neuropeptide that plays a crucial role in pain perception, inflammation, and various neurogenic processes. Its amino acid sequence is Arg-Pro-Arg-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2. This reagent is used in research to elucidate the mechanisms of neurogenic inflammation and to investigate the role of neuropeptides in signaling pathways related to pain and stress responses. Substance P (alligator) is valuable for studying neuropeptide interactions and their implications in various physiological and pathological conditions.
  27. Neuropeptide

    Tyr0-Neurokinin A is a tachykinin neuropeptide that acts as an agonist for the Tachykinin receptor 2 (Tacr2). This compound is significant in the study of metabolic disorders, particularly in understanding the mechanisms underlying insulin resistance, obesity, and diabetes. Its biological activity positions it as a valuable tool for advancing research in neuropeptide signaling and associated therapeutic targets.
  28. Peptide

    Kassinin is a neuropeptide derived from the Kassina frog, classified within the tachykinin family. It functions primarily as a signaling molecule in neuropeptide pathways and is released in response to stress as part of the organism's defense mechanism. This peptide is of interest in research focused on neurobiology, signaling pathways, and the study of amphibian defense mechanisms.
  29. NPBW1/2 Agonist

    Neuropeptide W-23 (human) is an endogenous agonist specifically targeting the NPBW1 (GPR7) and NPBW2 (GPR8) receptors. This neuropeptide plays a significant role in various physiological processes, including appetite regulation and stress response. Neuropeptide W-23 is primarily used in research applications focusing on neurobiology and metabolic disorders, providing insights into neural signaling pathways and potential therapeutic targets.
  30. Neuropeptide

    Biotinyl-neuropeptide W-23 (human) is a biotinylated analog of the neuropeptide W-23, which functions as an agonist of the NPBW1 (GPR7) and NPBW2 (GPR8) receptors. This compound modulates neuropeptide signaling pathways involved in various physiological processes, making it useful for investigating neuropeptide-related functions and signaling mechanisms in research applications. Biotinyl-neuropeptide W-23 facilitates the study of receptor interactions and offers potential insights into neurobiology and drug development.
  31. NPBW Agonist

    (Des-Bromo)-Neuropeptide B (1-23) (human) is an agonist for G-protein coupled receptors GPR7 (NPBW1) and GPR8 (NPBW2). It exhibits high affinity binding with inhibition constants (Kis) of 1.2 nM and 341 nM, respectively. This compound is valuable for investigating the neuropeptide signaling pathways and their roles in various physiological processes. It has applications in studies related to neurobiology, metabolic regulation, and receptor pharmacology.
  32. Stress Mediator

    Neuropeptide W-30 (human) is a significant stress mediator in the central nervous system, primarily targeting the hypothalamus-pituitary-adrenal (HPA) axis and modulating sympathetic outflow. As an endogenous ligand for the orphan G-protein-coupled receptors GPR7 and GPR8, Neuropeptide W-30 (human) binds and activates both receptors at comparable effective doses. This compound plays a crucial role in studies related to stress response and neuroendocrine regulation.
  33. Stress Mediator

    Neuropeptide W-30 (rat) primarily targets the G-protein-coupled receptors GPR7 and GPR8, functioning as a key mediator of stress within the central nervous system. It plays a crucial role in modulating the hypothalamus-pituitary-adrenal (HPA) axis and sympathetic outflow, influencing stress responses. Neuropeptide W-30 (rat) acts as an endogenous ligand for both receptors, demonstrating similar effective doses for binding and activation. This peptide is pertinent for research into stress-related disorders and neuroendocrine functions.
  34. NPFF1/NPFF2 Receptor Agonist

    Neuropeptide FF (NPFF) functions as an agonist for the NPFF1 and NPFF2 receptors, exhibiting Ki values of 2.82 nM and 0.21 nM, respectively. This octapeptide plays a crucial role in mediating various physiological processes, including the modulation of pain, opioids, autonomic function, and neuroendocrine responses. It is involved in the regulation of memory and the control of food and water intake, while also demonstrating significant antiopioid and analgesic properties. Neuropeptide FF is particularly relevant for research into opioid tolerance, morphine-induced analgesia, abstinence syndrome, and pain-related conditions, including inflammatory and neuropathic pain.
  35. NPFF-Related Peptides

    Neuropeptide FF (5-8) is a derivative of Neuropeptide FF that acts as a potent antagonist of NPFF-related receptors. This peptide, with the sequence Q-P-Q-R-F-NH2, exhibits a Ki value of 20.9 nM, indicating its strong binding affinity. It is primarily used in research to study pain modulation, stress responses, and neuroendocrine functions in various biological models.
  36. PrRP Fragment

    Prolactin-Releasing Peptide (12-31), bovine is a peptide fragment of prolactin-releasing peptide (PrRP), which is known for its role in modulating pain through RF-amide signaling. This peptide is primarily utilized in research focused on the nervous system, particularly in studies related to pain pathways and neurological disorders. Its specific biological activity makes it a valuable tool for exploring the mechanisms underlying nervous system diseases.
  37. Non-peptide NPSR Antagonist

    SHA 68 is a potent and selective non-peptide antagonist of the neuropeptide S receptor (NPSR), demonstrating IC50 values of 22.0 nM for NPSR Asn107 and 23.8 nM for NPSR Ile107. This compound exhibits limited blood-brain barrier penetration, making it suitable for research on peripheral applications and neuralgia. SHA 68 is valuable for studying the physiological roles of neuropeptide S and its potential implications in pain modulation and neurobiology.
  38. Neuropeptide

    Buccalin is a neuropeptide that primarily targets synaptic transmission at the neuromuscular junction. It effectively reduces the amplitude of motor neuron-induced muscle contractions when externally administered, acting presynaptically without influencing the rate of muscle relaxation. Buccalin diminishes excitatory junction potentials at the ARC while preserving the contractile response elicited directly through acetylcholine. This selective modulation makes it a valuable tool for research on synaptic mechanisms and neuropeptide function in neuromuscular signaling.
  39. Active Compound

    Neuropeptide Y (human, rat, mouse) is an active compound that plays a critical role in neuroprotection and modulation of neuronal activity. It has been shown to protect rat cortical neurons from β-Amyloid-induced toxicity, suggesting its potential relevance in Alzheimer's disease research. This peptide is commonly utilized in studies focused on neurodegenerative disorders and neuronal signaling pathways.
  40. Gut Hormone

    Peptide YY (PYY) is a human gut hormone primarily involved in appetite regulation and the inhibition of pancreatic secretions. It exerts its biological effects by interacting with Neuropeptide Y receptors. This peptide is valuable for research focused on metabolic disorders, appetite control, and the physiology of gastrointestinal hormones.
  41. Neuropeptide S receptor (NPSR) Agonist

    R06039-636 is a potent agonist of the Neuropeptide S receptor (NPSR), exhibiting an EC50 value of 94 nM. This compound plays a crucial role in modulating anxiety and stress responses, making it valuable for research into neuropsychiatric disorders. Its selective activation of NPSR provides insight into neuropeptide signaling pathways and can aid in the development of potential therapeutic strategies.
  42. NPY Y1 Receptor Agonist

    [Leu31,Pro34]-Neuropeptide Y (porcine) is a selective agonist of the neuropeptide Y Y1 receptor. This analog exhibits significant anxiolytic effects, making it a valuable tool for studying anxiety-related disorders. It is predominantly utilized in neuropharmacological research to explore the role of NPY in stress and anxiety modulation.
  43. Peptide

    Neuropeptide Y(29-64) is a peptide fragment comprising 36 amino acids derived from the larger neuropeptide Y. This fragment plays a critical role in modulating various physiological processes, including appetite regulation, anxiety, and stress response. Research applications include exploring neuropeptide signaling pathways and investigating the role of neuropeptides in neuropsychiatric disorders.
  44. NPY Receptor Y2 Agonist

    Neuropeptide Y (3-36) (human, rat) is an agonist of the Neuropeptide Y receptor Y2 (NPY Y2). This neuropeptide Y metabolite, generated by the action of dipeptidyl peptidase-4 (DPP4), has been shown to reduce the release of norepinephrine through its interaction with the Y2 receptor. It is primarily utilized in research related to neurophysiology and metabolic disorders, providing insights into pathways associated with appetite regulation and anxiety.
  45. Neuropeptide Y2 Receptor Agonist

    Neuropeptide Y (13-36), amide, human functions as a selective agonist for the neuropeptide Y2 receptor. This peptide is involved in various physiological processes, including appetite regulation, anxiety, and circadian rhythms. Researchers utilize this reagent to study neuropeptide signaling pathways and to explore therapeutic targets for metabolic and psychological disorders.
  46. Neuropeptide Y Receptor Agonist

    Pancreatic Polypeptide, human is a C-terminally amidated 36-amino acid peptide that functions as an agonist at the neuropeptide Y (NPY) Y4 and Y5 receptors. This compound is involved in the regulation of appetite and energy homeostasis, making it crucial for research in metabolic disorders and neurobiology. Its unique biological activity allows for valuable insights into the role of neuropeptides in physiological processes and potential therapeutic applications.
  47. Non-peptide Neuropeptide Neuropeptin Receptor Antagonist

    SR 142948A is a non-peptide antagonist of neuropeptide neuropeptin receptors, exhibiting high affinity for NT1 and NT2 subtypes. This compound is primarily utilized in research to elucidate the role of neuropeptides within the neurotransmitter system, with particular emphasis on their interactions with the dopamine system. Its ability to selectively inhibit these receptors makes it a valuable tool for studies investigating neuropeptide signaling pathways and their physiological implications.
  48. Neuropeptide Y2 Receptor Agonist

    Neuropeptide Y (13-36), porcine is a selective agonist of the neuropeptide Y2 receptor, known for its role in modulating appetite and stress response. This peptide fragment enhances neuropeptide Y signaling, making it a valuable tool for studying energy balance and neurophysiology. Its applications extend to research on metabolic disorders and neurobehavioral studies, facilitating a better understanding of neuropeptide interactions in various biological contexts.
  49. Pancreatic Peptide Secretion

    Pancreatic Polypeptide primarily targets pancreatic peptide secretion. This peptide is produced by the endocrine PP cells of the pancreas and plays a crucial role in regulating pancreatic secretory activities. Additionally, it influences hepatic glycogen storage and modulates gastrointestinal secretions, making it valuable for research in metabolic processes and gastrointestinal physiology.
  50. Bioactive Peptide

    Neuropeptide S (mouse) is a bioactive peptide that functions as a neurotransmitter and neuromodulator composed of 20 amino acids. This peptide plays a significant role in regulating various physiological processes, including arousal, anxiety, locomotion, feeding behaviors, memory, and substance addiction. It serves as an important tool for research in neurobiology and behavioral science, facilitating investigations into its impact on emotional and cognitive functions.

Items 2601-2650 of 3079

Page
per page
Set Descending Direction